Home > Drug Search >
  • company_query: BL&H
  •   > 
Drug Filter
Category:
chemistry (17) biology (21)
Status:
Approved (3) NDA Filing (9) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (13) Phase Ⅰ (8)
Clinical Stage:
Pending (8) Active (26) Discontinued (1)
Bio-Type:
Gene therapy (1) Vaccine (12) Animal extract (1) Recombinant enzyme (1) Recombinant cytokines (2) Recombinant hormone (1) Whole antibody (2) Fusion protein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Arthritis (1) Bladder cancer (2) Candidiasis (1) Chronic myeloid leukemia (CML ) (1) Clostridium difficile infection (1) Menopausal symptoms (1) Deep vein thrombosis (DVT) (1) Growth hormone deficit (1) Heart failure (1) Influenza virus infection (1) Thromboangiitis obliterans (1) Melanoma (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Erythropoietic protoporphyria (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (2) Parkinson's disease (PD) (1) Peripheral  neuropathy (1) Pulmonary arterial hypertension (1) Peyronie's disease (1) Schizophrenia (1) Solid tumours (2) Tuberculosis (1) Venous thromboembolism (VTE) (1) Head and neck cancer (1) Hodgkin lymphoma (1) Colorectal cancer (1) Radiodermatitis (1) Venezuelan equine encephalitis virus infection (1) Nosocomial Pneumonia (NP) (1) Unstable angina (1) Renal carcinoma (1) Hyperphosphatemia (1) Growth failure (1) Peritoneum cancer (1) Viral hemorrhagic fever (1) Staphylococcal infection (2) Glioblastoma (2) West nile virus infection (1) Dengue fever (1) Diabetic neuropathy (1) Liver cancer (1) Renal failure (1) Allergic diseases (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top